Robert Paul Smith Jr.
CIK: 0002003059
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Gossamer Bio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 24, 2026GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
5.8M shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
572K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
562.5K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
562.5K shares- - Mar 19, 2026GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
572K shares- - Jan 2, 2026GOSS
Gossamer Bio, Inc.
Award(A)Direct93.8K shares- - Oct 1, 2025GOSS
Gossamer Bio, Inc.
Award(A)Direct162.5K shares- - Mar 4, 2025GOSS
Gossamer Bio, Inc.
Award(A)DirectStock Option (Right to Buy)
572K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 24, 2026 | GOSS Gossamer Bio, Inc. | Award(A) Stock Option (Right to Buy) | 5,800,051 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 572,000 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 562,500 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Award(A) Stock Option (Right to Buy) | 562,500 | - | - | Direct |
| Mar 19, 2026 | GOSS Gossamer Bio, Inc. | Award(A) Stock Option (Right to Buy) | 572,000 | - | - | Direct |
| Jan 2, 2026 | GOSS Gossamer Bio, Inc. | Award(A) | 93,750 | - | $0 | Direct |
| Oct 1, 2025 | GOSS Gossamer Bio, Inc. | Award(A) | 162,500 | - | - | Direct |
| Mar 4, 2025 | GOSS Gossamer Bio, Inc. | Award(A) Stock Option (Right to Buy) | 572,000 | - | - | Direct |
1-8 of 8 transactions
About Smith Robert Paul JR
Smith Robert Paul JR (SEC CIK 0002003059) files insider reports with the SEC as Chief Commercial Officer of Gossamer Bio, Inc. (GOSS).
Signal8 holds 5 ownership filings by Smith Robert Paul JR, all Form 4s, filed between Mar 6, 2025 and Aug 26, 2026. Those filings report 8 transactions, from Mar 4, 2025 to Aug 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Smith Robert Paul JR's filings is in SAN DIEGO, CA.
Recent filings by Smith Robert Paul JR
- Aug 24, 2026: Grant or award of GOSS derivative securities (Form 4, code A).
- Mar 19, 2026: Disposition to issuer transactions of GOSS derivative securities (2 lines, Form 4, code D).
- Mar 19, 2026: Grants or awards of GOSS derivative securities (2 lines, Form 4, code A).
- Jan 2, 2026: Grant or award of GOSS shares (Form 4, code A).
- Oct 1, 2025: Grant or award of GOSS shares (Form 4, code A).
Other insiders filing for Gossamer Bio, Inc. (GOSS)
- Milligan Sandra, Director
- Daniel Thomas O, Director
- Ciongoli Gregory Austin, Director
- Drynan Skye, Director
- Quisel John D, Director
- Cox Russell J., Director